FDA Approves Artesunate for Injection for the Treatment of Severe Malaria

Article Link: FDA Approves Artesunate for Injection for the Treatment of Severe Malaria

FREDERICK, Md., May 27, 2020 /PRNewswire/ — Amivas (US), LLC, specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today that Artesunate for Injection 110 mg, powder and solvent for solution has…

Source: FDA New Drug Approvals